Singapore: Japanese drugmaker Daiichi Sankyo, which currently holds a majority stake in Ranbaxy, had earlier highlighted that it believes that former shareholders of Ranbaxy concealed and misrepresented critical information concerning the... Read more
Singapore: An US FDA panel has voted that Merck & Co experimental insomnia drug appears to be safe and effective, despite... Read more
Singapore: Johnson & Johnson (J&J) revealed that it is aiming to apply for approval of 10 new drugs in the US and Europe,... Read more
Singapore: Ranbaxy Laboratories is contemplating on slashing its global sales staff by about a third, with a majority of the job cuts expected... Read more
Singapore: Breaking its silence for the first time in 10 days after Indian drug major Ranbaxy's $500 million settlement of the US Food and... Read more
Singapore: Ranbaxy Laboratories highlighted some of the major specific actions the company has been taking in recent years to address certain... Read more
Singapore: Sanofi joined hands with Axway in order to streamline processes and transform its technology infrastructure into an efficient... Read more
Singapore: GlaxoSmithKline (GSK) launched Discovery Fast Track, a competition designed to accelerate the translation of academic research... Read more
Singapore: Pfizer has discontinued its phase III randomized, open-label, two-arm study (B1931008) evaluating the safety and efficacy of... Read more
Singapore: Australia-based Alchemia has provided commercial update on four of its key projects, including its marketed drug fondaparinux;... Read more
Singapore: A new study by research and consulting firm GlobalData, highlighted that Japan's chronic myeloid leukemia (CML) market is going... Read more
Singapore: AstraZeneca is looking to move its research and global headquarters to Cambridge, UK, and has zeroed in on a site located at... Read more
Survey Box